Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. Apontis Pharma AG
  6. Financials
    APPH   DE000A3CMGM5

APONTIS PHARMA AG

(APPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021 2022 2023
Net sales1 39,248,757,868,6
EBITDA1 -5,609,0513,7
Operating profit (EBIT)1 -4,357,0511,5
Operating Margin -8,94%12,2%16,7%
Pre-Tax Profit (EBT)1 -3,656,8011,2
Net income1 -1,182,905,158,55
Net margin -3,01%5,96%8,92%12,5%
EPS2 -0,350,611,01
Dividend per Share2 ----
Announcement Date 04/29/2021---
1 EUR in Million
2 EUR
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023
Net Debt1 ----
Net Cash position1 -28,828,933,2
Leverage (Debt / EBITDA) --5,13x-3,19x-2,42x
Free Cash Flow1 -0,850,204,15
ROE (Net Profit / Equities) -10,9%11,3%16,0%
Shareholders' equity1 -26,745,653,6
ROA (Net Profit / Asset) ----
Assets1 ----
Book Value Per Share2 -4,705,105,80
Cash Flow per Share ----
Capex1 -3,557,307,30
Capex / Sales -7,30%12,6%10,6%
Announcement Date 04/29/2021---
1 EUR in Million
2 EUR
Key data
Capitalization (EUR) 167 450 000
Capitalization (USD) 197 697 757
Net sales (EUR) 39 240 400
Net sales (USD) 46 514 393
Number of employees 195
Sales / Employee (EUR) 201 233
Sales / Employee (USD) 238 535
Avg. Exchange 20 sessions (EUR) 19 678
Avg. Exchange 20 sessions (USD) 23 326
Average Daily Capital Traded 0,01%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA